Health
U.S. COVID vaccine hopeful using Gates Foundation cash to prepare for human trial – Devdiscourse
The Swiss company’s gene therapy unit is backing the project with technical assistance and supply. Other COVID-19 vaccines use viral vectors, too, though AstraZeneca…
Scientists who normally focus on fixing defective genes said on Friday that up to $2.1 million from the Bill & Melinda Gates Foundation will help them move their COVID-19 vaccine candidate toward 2021 human trials.
Harvard University scientist Luk Vandenberghe and University of Pennsylvania gene therapy head James Wilson said primate safety and efficacy tests have proven promising for their single-dose candidate, targeted for room-temperature storage. “We believe there is real potential,” Vandenberghe…
-
Noosa News23 hours agoPort of Brisbane fails to trademark logo
-
Noosa News23 hours agoWhich nation has the best-paid teachers? Take the Brisbane Times Quiz
-
Noosa News14 hours agoWin double passes to Heart of Gold!
-
General22 hours agoFormer Roebuck Bay Hotel worker tells court of repeated indecent assaults